Volume 10 Supplement 2
Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.
Edited by Hamid Arabnia, Wenbing Zhao and Hong Zhou.
Chronic inflammation has been widely considered to be the major risk factor of coronary heart disease (CHD). The goal of our study was to explore the possible association with CHD for inflammation-related sing...
Innumerable opportunities for new genomic research have been stimulated by advancement in high-throughput next-generation sequencing (NGS). However, the pitfall of NGS data abundance is the complication of dis...
Protein complexes play an important role in biological processes. Recent developments in experiments have resulted in the publication of many high-quality, large-scale protein-protein interaction (PPI) dataset...
Snail is a typical transcription factor that could induce epithelial-mesenchymal transition (EMT) and cancer progression. There are some related reports about the clinical significance of snail protein express...
Methylation changes are frequent in cancers, but understanding how hyper- and hypomethylated region changes coordinate, associate with genomic features, and affect gene expression is needed to better understan...
Green tea polyphenol epigallocatechin-3-gallate (EGCG) has been demonstrated to inhibit cancer in experimental studies through its antioxidant activity and modulations on cellular functions by binding specific...
2022 Citation Impact
4.5 - 2-year Impact Factor
4.9 - 5-year Impact Factor
0.823 - SNIP (Source Normalized Impact per Paper)
1.308 - SJR (SCImago Journal Rank)
2023 Speed
13 days submission to first editorial decision for all manuscripts (Median)
91 days submission to accept (Median)
2023 Usage
761,045 downloads
816 Altmetric mentions
Human Genomics